Terms: = Leukemia AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
32 results:
1. Simultaneous quantification of venetoclax and voriconazole in human plasma by UHPLC-MS/MS and its application in acute myeloid leukemia patients.
Gao P; Zhang W; Fang X; Leng B; Zhang Y; Liu X; Wang X; Guo N
J Pharm Biomed Anal; 2023 Apr; 227():115279. PubMed ID: 36739719
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf treatment of AML and B-ALL.
Ureña-Bailén G; Dobrowolski JM; Hou Y; Dirlam A; Roig-Merino A; Schleicher S; Atar D; Seitz C; Feucht J; Antony JS; Mohammadian Gol T; Handgretinger R; Mezger M
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361619
[TBL] [Abstract] [Full Text] [Related]
3. [Predictive Value of Acute Phase Proteins on the Prognosis of Patients with Acute Myeloid leukemia].
Wu XJ; Wang YQ; Yang XY; Lin XS; Qiu MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1086-1093. PubMed ID: 35981366
[TBL] [Abstract] [Full Text] [Related]
4. Quantification of Venetoclax for Therapeutic Drug Monitoring in Chinese Acute Myeloid leukemia Patients by a Validated UPLC-MS/MS Method.
Yang X; Mei C; He X; He L; Lu X; Tong H; Lou Y
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268708
[TBL] [Abstract] [Full Text] [Related]
5. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
Heltemes-Harris LM; Hubbard GK; LaRue RS; Munro SA; Yang R; Henzler CM; Starr TK; Sarver AL; Kornblau SM; Farrar MA
Oncogene; 2021 Oct; 40(43):6166-6179. PubMed ID: 34535769
[TBL] [Abstract] [Full Text] [Related]
6. Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous leukemia in Adults.
Metheny L; Callander NS; Hall AC; Zhang MJ; Bo-Subait K; Wang HL; Agrawal V; Al-Homsi AS; Assal A; Bacher U; Beitinjaneh A; Bejanyan N; Bhatt VR; Bredeson C; Byrne M; Cairo M; Cerny J; DeFilipp Z; Perez MAD; Freytes CO; Ganguly S; Grunwald MR; Hashmi S; Hildebrandt GC; Inamoto Y; Kanakry CG; Kharfan-Dabaja MA; Lazarus HM; Lee JW; Nathan S; Nishihori T; Olsson RF; Ringdén O; Rizzieri D; Savani BN; Savoie ML; Seo S; van der Poel M; Verdonck LF; Wagner JL; Yared JA; Hourigan CS; Kebriaei P; Litzow M; Sandmaier BM; Saber W; Weisdorf D; de Lima M
Transplant Cell Ther; 2021 Nov; 27(11):923.e1-923.e12. PubMed ID: 34428556
[TBL] [Abstract] [Full Text] [Related]
7. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8
Braun M; Aguilera AR; Sundarrajan A; Corvino D; Stannard K; Krumeich S; Das I; Lima LG; Meza Guzman LG; Li K; Li R; Salim N; Jorge MV; Ham S; Kelly G; Vari F; Lepletier A; Raghavendra A; Pearson S; Madore J; Jacquelin S; Effern M; Quine B; Koufariotis LT; Casey M; Nakamura K; Seo EY; Hölzel M; Geyer M; Kristiansen G; Taheri T; Ahern E; Hughes BGM; Wilmott JS; Long GV; Scolyer RA; Batstone MD; Landsberg J; Dietrich D; Pop OT; Flatz L; Dougall WC; Veillette A; Nicholson SE; Möller A; Johnston RJ; Martinet L; Smyth MJ; Bald T
Immunity; 2020 Oct; 53(4):805-823.e15. PubMed ID: 33053330
[TBL] [Abstract] [Full Text] [Related]
8. [Evaluation of the efficacy of cyclosporin A combined with recombined human thrombopoietin for treating patients with non-severe aplastic anemia].
Zhang ML; Chen WS; Han B
Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):637-642. PubMed ID: 32942816
[No Abstract] [Full Text] [Related]
9. Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives.
van Heerden J; Zaghloul M; Neven A; de Rojas T; Geel J; Patte C; Balagadde-Kambugu J; Hesseling P; Tchintseme F; Bouffet E; Hessissen L;
JCO Glob Oncol; 2020 Aug; 6():1264-1275. PubMed ID: 32762563
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors.
Okamoto S; Ureshino H; Kawaguchi A; Miyazono M; Ikeda Y; Kimura S
Int J Hematol; 2020 Jul; 112(1):41-45. PubMed ID: 32306183
[TBL] [Abstract] [Full Text] [Related]
11. [The influence of additive clonal chromosome abnormalities in Ph negative cells on the efficacy of chronic myeloid leukemia].
Zhao HF; Zhang Y; Zu YL; Li Z; Zhou J; Yu FK; Hu JY; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):803-807. PubMed ID: 31665854
[No Abstract] [Full Text] [Related]
12. Secondhand smoke: A new and modifiable prognostic factor in childhood acute lymphoblastic leukemias.
Cárceles-Álvarez A; Ortega-García JA; López-Hernández FA; Fuster-Soler JL; Ramis R; Kloosterman N; Castillo L; Sánchez-Solís M; Claudio L; Ferris-Tortajada J
Environ Res; 2019 Nov; 178():108689. PubMed ID: 31479979
[TBL] [Abstract] [Full Text] [Related]
13. Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Dietz AC; Seidel K; Leisenring WM; Mulrooney DA; Tersak JM; Glick RD; Burnweit CA; Green DM; Diller LR; Smith SA; Howell RM; Stovall M; Armstrong GT; Oeffinger KC; Robison LL; Termuhlen AM
Lancet Oncol; 2019 Oct; 20(10):1420-1431. PubMed ID: 31471158
[TBL] [Abstract] [Full Text] [Related]
14. Crenolanib-Derived Probes Suitable for Cell- and Tissue-Based Protein Profiling and Single-Cell Imaging.
Chang Y; Zhu D; Guo H; Yin X; Ding K; Li Z
Chembiochem; 2019 Jul; 20(14):1783-1788. PubMed ID: 30942519
[TBL] [Abstract] [Full Text] [Related]
15. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Saussele S; Richter J; Guilhot J; Gruber FX; Hjorth-Hansen H; Almeida A; Janssen JJWM; Mayer J; Koskenvesa P; Panayiotidis P; Olsson-Strömberg U; Martinez-Lopez J; Rousselot P; Vestergaard H; Ehrencrona H; Kairisto V; Machová Poláková K; Müller MC; Mustjoki S; Berger MG; Fabarius A; Hofmann WK; Hochhaus A; Pfirrmann M; Mahon FX;
Lancet Oncol; 2018 Jun; 19(6):747-757. PubMed ID: 29735299
[TBL] [Abstract] [Full Text] [Related]
16. NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.
Märklin M; Heitmann JS; Fuchs AR; Truckenmüller FM; Gutknecht M; Bugl S; Saur SJ; Lazarus J; Kohlhofer U; Quintanilla-Martinez L; Rammensee HG; Salih HR; Kopp HG; Haap M; Kirschniak A; Kanz L; Rao A; Wirths S; Müller MR
Nat Commun; 2017 Oct; 8(1):755. PubMed ID: 28970470
[TBL] [Abstract] [Full Text] [Related]
17. Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA.
Merrill RM; Johnson E
J Cancer Surviv; 2017 Oct; 11(5):578-589. PubMed ID: 28770444
[TBL] [Abstract] [Full Text] [Related]
18. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract] [Full Text] [Related]
19. Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth.
Qin L; Tian Y; Yu Z; Shi D; Wang J; Zhang C; Peng R; Chen X; Liu C; Chen Y; Huang W; Deng W
Oncotarget; 2016 Jan; 7(2):1395-407. PubMed ID: 26593251
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical feature and prognosis analysis of elderly patients with polythemia vera].
Xiao X; Zhao M; Meng J; Li Q; Mu J; Li X; Lü H; Liu P; Deng Q; Geng L; Li Y
Zhonghua Yi Xue Za Zhi; 2015 May; 95(18):1374-7. PubMed ID: 26178352
[TBL] [Abstract] [Full Text] [Related]
[Next]
